Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient — Stella

Home/Sickle Cell Disease (SCD)/

View on ClinicalTrials.gov

Recruiting

Back to Sickle Cell Disease (SCD) trials

Trial locations(1 site)

France

CHU de Toulouse, Toulouse, France

Key details

Sponsor

University Hospital, Toulouse

Enrollment target

~40 participants

Started

March 2025

Primary completion

April 2027

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.